(Q40746393)

23 September 2017

title

A study of the effect of chemical inactivants on the epitopes of Rift Valley fever virus glycoproteins using monoclonal antibodies (English)

1 reference

https://api.crossref.org/works/10.1016/0166-0934(91)90036-Y

Rift Valley fever phlebovirus

9 November 2022

main subject

0 references

Rift Valley fever

1 reference

based on heuristic

inferred from title

Rift Valley fever virus

object named as

Rift Valley fever virus

1 reference

N. K. Blackburn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1723736

9 November 2022

T. G. Besselaar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1723736

9 November 2022

language of work or name

1 reference

1 August 1991

1 reference

full work available at URL

23 September 2017

https://api.elsevier.com/content/article/PII:016609349190036Y?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0166-0934(91)90036-Y

https://api.elsevier.com/content/article/PII:016609349190036Y?httpAccept=text/plain

9 November 2022

1 reference

https://api.crossref.org/works/10.1016/0166-0934(91)90036-Y

Journal of Virological Methods

9 November 2022

published in

1 reference

23 September 2017

volume

33

1 reference

23 September 2017

issue

3

1 reference

23 September 2017

page(s)

367-374

1 reference

describes a project that uses

23 September 2017

1 reference

Binary ethylenimine as an inactivant for foot-and-mouth disease virus and its application for vaccine production

1

1 reference

https://api.crossref.org/works/10.1016/0166-0934(91)90036-Y

Formaldehyde inactivation of foot-and-mouth disease virus. Conditions for the preparation of safe vaccine

9 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0166-0934(91)90036-Y

Antigenic analysis of West Nile virus strains using monoclonal antibodies

9 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0166-0934(91)90036-Y

A preliminary vaccine potency trial of a Newcastle disease virus inactivated with binary ethylenimine

9 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0166-0934(91)90036-Y

Effects of formalin inactivation on bovine herpes virus-1 glycoproteins and antibody response elicited by formalin-inactivated vaccines in rabbits

9 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0166-0934(91)90036-Y

Epitope mapping of flavivirus glycoproteins.

9 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0166-0934(91)90036-Y

Antigenic variation among members of the tick-borne encephalitis complex

9 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0166-0934(91)90036-Y

Characterization of a double avirulent mutant of rabies virus and its potency as a vaccine, live or inactivated

9 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0166-0934(91)90036-Y

9 November 2022

Identifiers

1 reference

23 September 2017

1 reference